While I'm pretty sure that your post is not an admission on your part that you posted untrue information by stating that as chairman of the executive committee CJ would be due Chairman of the Board pay structure, at least you're post shows that you know that CJ is not the Charman of the Board. I'm relatively ceratin you already knew that prior to your earlier post on the subject as well.

The FACT is that since Pohl resigned, PTSC has had no Chairman of the Board if Directors. Furthermore, to illustrate the difference between the two positions, CJ has been Chairman of the Executive Committee for many years. In FACT, he held that position at the same time that David Pohl held the Chairman of the Board of Directors position. So clearly, they are separate and distinct roles, even at PTSC, despite your attempts to compare them in the earlier discussion regarding the comparison of BOD cash fee's of PTSC, and the Fortune 500 Unisys. There's a significant difference between being the chairman of a committee, and being THE CHAIRMAN, just ask Frank Sinatra!

For anyone who wants to know the FACTS, simply refer to the PTSC Proxy Filing from April 2007 which includes the following:

CARLTON M. JOHNSON, JR. Carlton Johnson has served as a Director of the Company since 2001, and is Chairman of the Executive Committee of the Board of Directors. Mr. Johnson is in-house legal counsel for Roswell Capital Partners, LLC, a position he has held since June 1996. Mr. Johnson has been admitted to the practice of law in Alabama since 1986, Florida since 1982 and Georgia since 1997. He has been a shareholder in the Pensacola, Florida AV- rated law firm of Smith, Sauer, DeMaria Johnson and was President-Elect of the 500 member Escambia-Santa Rosa Bar Association. He also served on the Florida Bar Young Lawyers Division Board of Governors. Mr. Johnson earned a degree in History/Political Science at Auburn University and Juris Doctor at Samford University - Cumberland School of Law. Mr. Johnson is also a director and member of the audit committee of Peregrine Pharmaceuticals, Inc., a publicly held company.

DAVID H. POHL. David Pohl has served as a Director of the Company since April 2001, and served as an officer of the Company from January 2001 to March 2002. He was elected Chairman, Chief Executive Officer and President on June 13, 2005. Except for his service with the Company, Mr. Pohl has been in the private practice of law counseling business clients since 1997, and most recently was Of Counsel with the law firm of Herold & Sager in Encinitas, California. He is a member of the Intellectual Property Law and Business Law Sections of the State Bar of California. In 1995 and 1996, Mr. Pohl was Special Counsel to the Ohio Attorney General regarding investments in entrepreneurial firms by state pension funds. Previously he was a senior attorney with a large U.S. law firm, and held positions as a senior officer and general counsel in large financial services corporations. Mr. Pohl earned a J.D. degree in 1962 from The Ohio State University College of Law, and also holds a B.S. in Administrative Sciences from Ohio State. Mr. Pohl is also a director and member of the audit committee of Peregrine Pharmaceuticals, Inc., a publicly held company.